Symbol="ONCT"
AssetType="Common Stock"
Name="Oncternal Therapeutics Inc"
Description="Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of cancer therapies for cancers with critical unmet medical needs. The company is headquartered in San Diego, California."
CIK="1260990"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12230 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18280400"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.769"
DividendPerShare="0"
DividendYield="0"
EPS="-0.79"
RevenuePerShareTTM="0.015"
ProfitMargin="0"
OperatingMarginTTM="-52.12"
ReturnOnAssetsTTM="-0.424"
ReturnOnEquityTTM="-0.721"
RevenueTTM="862000"
GrossProfitTTM="-31490000"
DilutedEPSTTM="-0.79"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.445"
AnalystTargetPrice="1.9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.64"
PriceToBookRatio="0.879"
EVToRevenue="0.853"
EVToEBITDA="0.249"
Beta="1.363"
num_52WeekHigh="1.33"
num_52WeekLow="0.26"
num_50DayMovingAverage="0.374"
num_200DayMovingAverage="0.668"
SharesOutstanding="58969000"
DividendDate="2019-06-10"
ExDividendDate="None"
symbol="ONCT"
open="0.31"
high="0.35"
low="0.30"
price="0.34"
volume="229664.00"
latest_trading_day="2023-08-23"
previous_close="0.31"
change="0.03"
change_percent="8.5484%"
aroon_positive_momentum_days="38"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="443517"
Change_recent_avg="0.01"
Delta_recent_avg="0.03"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
